Insights into Mechanisms Used by Staphylococcus aureus to Avoid Destruction by Human Neutrophils
暂无分享,去创建一个
Adeline R. Whitney | J. Musser | D. Sturdevant | S. Porcella | F. DeLeo | D. Dorward | J. Voyich | K. Braughton | D. Gardner | Barry N. Kreiswirth | R. Long | B. Saı̈d-Salim | B. Kreiswirth | Jovanka M. Voyich
[1] M. Moorhouse,et al. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. , 2004, The Journal of clinical investigation.
[2] J. Musser,et al. Synthesis and Deformylation of Staphylococcus aureus δ-Toxin Are Linked to Tricarboxylic Acid Cycle Activity , 2003, Journal of bacteriology.
[3] K. Bayles. The bactericidal action of penicillin: new clues to an unsolved mystery. , 2000, Trends in microbiology.
[4] F. DeLeo,et al. An apoptosis differentiation programme in human polymorphonuclear leucocytes. , 2004, Biochemical Society transactions.
[5] Y. S. Sathe,et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.
[6] R. Lynfield,et al. Methicillin-resistant Staphylococcus aureus disease in three communities. , 2005, The New England journal of medicine.
[7] E. Gorak,et al. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] H. Gresham,et al. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. , 2004, FEMS immunology and medical microbiology.
[9] B. Barrell,et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Shukla,et al. Emergence and Spread of Community-Associated Methicillin-Resistant Staphylococcus aureus in Rural Wisconsin, 1989 to 1999 , 2004, Journal of Clinical Microbiology.
[11] Mian Cai,et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] H. Mori,et al. Two‐component system VraSR positively modulates the regulation of cell‐wall biosynthesis pathway in Staphylococcus aureus , 2003, Molecular microbiology.
[13] J. Musser,et al. Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens. , 2004, Microbes and infection.
[14] Adeline R. Whitney,et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Musser,et al. Engagement of the Pathogen Survival Response Used by Group A Streptococcus to Avert Destruction by Innate Host Defense , 2004, The Journal of Immunology.
[16] J. Musser,et al. An apoptosis‐differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation , 2003, Journal of leukocyte biology.
[17] A. Tarkowski,et al. Role of Neutrophil Leukocytes in Cutaneous Infection Caused by Staphylococcus aureus , 2000, Infection and Immunity.
[18] P. Vanhems,et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients , 2002, The Lancet.
[19] E. Graviss,et al. Molecular Characteristics of Nosocomial and Native American Community-Associated Methicillin-Resistant Staphylococcus aureus Clones from Rural Wisconsin , 2004, Journal of Clinical Microbiology.
[20] W. Shafer,et al. Genetics of staphylococcal enterotoxin B in methicillin-resistant isolates of Staphylococcus aureus , 1979, Infection and immunity.
[21] E. Glass,et al. Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Ayoub,et al. Toxic shock syndrome caused by a strain of Staphylococcus aureus that produces enterotoxin C but not toxic shock syndrome toxin-1. , 1989, American journal of diseases of children.
[23] Robert M. Stahl,et al. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: Cell fate is regulated at the level of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] Y. Nagai,et al. Genome and virulence determinants of high virulence community-acquired MRSA , 2002, The Lancet.
[25] H. Chambers,et al. Community-associated MRSA--resistance and virulence converge. , 2005, The New England journal of medicine.
[26] James M. Musser,et al. Evolutionary genomics of Staphylococcus aureus: Insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Kreiswirth,et al. Community-Acquired Methicillin-Resistant Staphylococcus aureus: An Emerging Pathogen , 2003, Infection Control & Hospital Epidemiology.
[28] M. Bischoff,et al. Transcription of the Staphylococcus aureus cid and lrg Murein Hydrolase Regulators Is Affected by Sigma Factor B , 2004, Journal of bacteriology.
[29] J. Bull,et al. Chronic neutropenia. , 1979, Medicine.
[30] Paul M. Orwin,et al. Exotoxins of Staphylococcus aureus. , 2000, Clinical microbiology reviews.
[31] Amy V. Groom,et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. , 2001, JAMA.
[32] Arjun Srinivasan,et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. , 2005, The New England journal of medicine.
[33] E. Brunskill,et al. Analysis of Genetic Elements ControllingStaphylococcus aureus lrgAB Expression: Potential Role of DNA Topology in SarA Regulation , 2000, Journal of bacteriology.
[34] Brad Spellberg,et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. , 2005, The New England journal of medicine.
[35] Katherine O'Riordan,et al. Staphylococcus aureus Capsular Polysaccharides , 2004, Clinical Microbiology Reviews.
[36] Nancy L Barrett,et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] F. Vandenesch,et al. Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence , 2003, Emerging infectious diseases.
[38] R. Novick. Autoinduction and signal transduction in the regulation of staphylococcal virulence , 2003, Molecular microbiology.
[39] B. Wilson,et al. Survival of Staphylococcus aureus Inside Neutrophils Contributes to Infection1 , 2000, The Journal of Immunology.
[40] A. Tarkowski,et al. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus , 1997, Infection and immunity.
[41] T. Stossel,et al. Chronic neutropenia in childhood: Analysis of 16 cases and a review of the literature , 1976 .
[42] G. Viero,et al. Ion channels and bacterial infection: the case of β‐barrel pore‐forming protein toxins of Staphylococcus aureus , 2003, FEBS letters.
[43] F. DeLeo,et al. NADPH oxidase activation and assembly during phagocytosis. , 1999, Journal of immunology.
[44] Amy V. Groom,et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. , 1999, MMWR. Morbidity and mortality weekly report.
[46] Susan K. Johnson,et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. , 2003, JAMA.
[47] S. Roberts,et al. AGRANULOCYTOSIS: REPORT OF A CASE , 1930 .
[48] F. DeLeo,et al. Differential Distribution and Expression of Panton-Valentine Leucocidin among Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains , 2005, Journal of Clinical Microbiology.
[49] S. McAllister,et al. Pulsed-Field Gel Electrophoresis Typing of Oxacillin-Resistant Staphylococcus aureus Isolates from the United States: Establishing a National Database , 2003, Journal of Clinical Microbiology.
[50] A. Conde. Staphylococcus aureus infections. , 1998, The New England journal of medicine.
[51] J. Lekstrom‐Himes,et al. Immunodeficiency diseases caused by defects in phagocytes. , 2000, The New England journal of medicine.
[52] D. Lauderdale,et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. , 1998, JAMA.